APO Research
Talk to an analyst

APO RESEARCH · REPORT

Isoniazid Tablets

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Isoniazid Tablets Market Outlook and Growth Opportunities 2026

29 December 2025214 pages

Choose your research edition.

Industry ResearchIsoniazid Tablets Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal Isoniazid Tablets Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Isoniazid Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Isoniazid Tablets Market Outlook and Growth Opportunities 2026214 pages · $4,250 USDMarket Analysis & ForecastGlobal Isoniazid Tablets Market Analysis and Forecast 2026-2032211 pages · $4,950 USD

Market perspective

The global Isoniazid Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Isoniazid Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Isoniazid Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Isoniazid Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Isoniazid Tablets market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Isoniazid Tablets market include Yunpeng Pharmaceutical Group Co., Ltd., Tonghua Baishan Pharmaceutical Co., Ltd., Tiansheng Pharmaceutical Group Co., Ltd., Sichuan Deyuan Pharmaceutical Group Co., Ltd., Sancai Shiqi Pharmaceutical Co., Ltd., Jiangxi Haiersi Pharmaceutical Co., Ltd., Jichuang Pharmaceutical Group Co., Ltd., Hunan Xinhui Pharmaceutical Co., Ltd. and Hunan Shentaichun Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Isoniazid Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Isoniazid Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Isoniazid Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Isoniazid Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Isoniazid Tablets Segment by Company

Yunpeng Pharmaceutical Group Co., Ltd.

Tonghua Baishan Pharmaceutical Co., Ltd.

Tiansheng Pharmaceutical Group Co., Ltd.

Sichuan Deyuan Pharmaceutical Group Co., Ltd.

Sancai Shiqi Pharmaceutical Co., Ltd.

Jiangxi Haiersi Pharmaceutical Co., Ltd.

Jichuang Pharmaceutical Group Co., Ltd.

Hunan Xinhui Pharmaceutical Co., Ltd.

Hunan Shentaichun Pharmaceutical Co., Ltd.

Hunan Kangerjia Pharmaceutical Co., Ltd.

Hunan Hansen Pharmaceutical Co., Ltd.

Hunan Erkang Pharmaceutical Co., Ltd.

Hubei Renyue Pharmaceutical Co., Ltd.

Hubei Hendi Pharmaceutical Co., Ltd.

Hebei Changtian Pharmaceutical Co., Ltd.

Hebei Tiancheng Pharmaceutical Co., Ltd.

Hangzhou Minsheng Pharmaceutical Co., Ltd.

Harbin Pharmaceutical Group Pharmaceutical Factory

Sinopharm Guorui Pharmaceutical Co., Ltd.

Guilin Nanyao Co., Ltd.

Guangdong Xinfeng Pharmaceutical Co., Ltd.

Isoniazid Tablets Segment by Type

50mg

100mg

Isoniazid Tablets Segment by Application

Hospital

Clinic

Other

Isoniazid Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Isoniazid Tablets status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Isoniazid Tablets market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Isoniazid Tablets significant trends, drivers, influence factors in global and regions.

6. To analyze Isoniazid Tablets competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Isoniazid Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Isoniazid Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Isoniazid Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Isoniazid Tablets market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Isoniazid Tablets industry.

Chapter 3: Detailed analysis of Isoniazid Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Isoniazid Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Isoniazid Tablets in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Isoniazid Tablets Industry Trends Table 2. Isoniazid Tablets Industry Drivers Table 3. Isoniazid Tablets Industry Opportunities and Challenges Table 4. Isoniazid Tablets Industry Restraints Table 5. Global Isoniazid Tablets Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Isoniazid Tablets Revenue Share by Company (2021-2026) Table 7. Global Isoniazid Tablets Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Isoniazid Tablets Sales Volume Share by Company (2021-2026) Table 9. Global Isoniazid Tablets Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Isoniazid Tablets Company Ranking, (2024-2026) & (USD Million) Table 11. Global Isoniazid Tablets Key Company Manufacturing Base & Headquarters Table 12. Global Isoniazid Tablets Company, Product Type & Application Table 13. Global Isoniazid Tablets Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Isoniazid Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 50mg Table 18. Significant Companies of 100mg Table 19. Global Isoniazid Tablets Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Isoniazid Tablets Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Isoniazid Tablets Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Isoniazid Tablets Sales Volume Share by Type (2021-2026) Table 23. Global Isoniazid Tablets Sales Volume Share by Type (2027-2032) Table 24. Global Isoniazid Tablets Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Isoniazid Tablets Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Isoniazid Tablets Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Isoniazid Tablets Sales Value Share by Type (2021-2026) Table 28. Global Isoniazid Tablets Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Clinic Table 31. Significant Companies of Other Table 32. Global Isoniazid Tablets Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Isoniazid Tablets Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Isoniazid Tablets Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Isoniazid Tablets Sales Volume Share by Application (2021-2026) Table 36. Global Isoniazid Tablets Sales Volume Share by Application (2027-2032) Table 37. Global Isoniazid Tablets Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Isoniazid Tablets Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Isoniazid Tablets Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Isoniazid Tablets Sales Value Share by Application (2021-2026) Table 41. Global Isoniazid Tablets Sales Value Share by Application (2027-2032) Table 42. Global Isoniazid Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Isoniazid Tablets Sales by Region (2021-2026) & (K Units) Table 44. Global Isoniazid Tablets Sales Market Share by Region (2021-2026) Table 45. Global Isoniazid Tablets Sales by Region (2027-2032) & (K Units) Table 46. Global Isoniazid Tablets Sales Market Share by Region (2027-2032) Table 47. Global Isoniazid Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Isoniazid Tablets Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Isoniazid Tablets Sales Value Share by Region (2021-2026) Table 50. Global Isoniazid Tablets Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Isoniazid Tablets Sales Value Share by Region (2027-2032) Table 52. Global Isoniazid Tablets Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Isoniazid Tablets Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Isoniazid Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Isoniazid Tablets Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Isoniazid Tablets Sales by Country (2021-2026) & (K Units) Table 57. Global Isoniazid Tablets Sales Market Share by Country (2021-2026) Table 58. Global Isoniazid Tablets Sales by Country (2027-2032) & (K Units) Table 59. Global Isoniazid Tablets Sales Market Share by Country (2027-2032) Table 60. Global Isoniazid Tablets Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Isoniazid Tablets Sales Value Market Share by Country (2021-2026) Table 62. Global Isoniazid Tablets Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Isoniazid Tablets Sales Value Market Share by Country (2027-2032) Table 64. Yunpeng Pharmaceutical Group Co., Ltd. Company Information Table 65. Yunpeng Pharmaceutical Group Co., Ltd. Business Overview Table 66. Yunpeng Pharmaceutical Group Co., Ltd. Isoniazid Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Yunpeng Pharmaceutical Group Co., Ltd. Isoniazid Tablets Product Portfolio Table 68. Yunpeng Pharmaceutical Group Co., Ltd. Recent Development Table 69. Tonghua Baishan Pharmaceutical Co., Ltd. Company Information Table 70. Tonghua Baishan Pharmaceutical Co., Ltd. Business Overview Table 71. Tonghua Baishan Pharmaceutical Co., Ltd. Isoniazid Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Tonghua Baishan Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio Table 73. Tonghua Baishan Pharmaceutical Co., Ltd. Recent Development Table 74. Tiansheng Pharmaceutical Group Co., Ltd. Company Information Table 75. Tiansheng Pharmaceutical Group Co., Ltd. Business Overview Table 76. Tiansheng Pharmaceutical Group Co., Ltd. Isoniazid Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Tiansheng Pharmaceutical Group Co., Ltd. Isoniazid Tablets Product Portfolio Table 78. Tiansheng Pharmaceutical Group Co., Ltd. Recent Development Table 79. Sichuan Deyuan Pharmaceutical Group Co., Ltd. Company Information Table 80. Sichuan Deyuan Pharmaceutical Group Co., Ltd. Business Overview Table 81. Sichuan Deyuan Pharmaceutical Group Co., Ltd. Isoniazid Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Sichuan Deyuan Pharmaceutical Group Co., Ltd. Isoniazid Tablets Product Portfolio Table 83. Sichuan Deyuan Pharmaceutical Group Co., Ltd. Recent Development Table 84. Sancai Shiqi Pharmaceutical Co., Ltd. Company Information Table 85. Sancai Shiqi Pharmaceutical Co., Ltd. Business Overview Table 86. Sancai Shiqi Pharmaceutical Co., Ltd. Isoniazid Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Sancai Shiqi Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio Table 88. Sancai Shiqi Pharmaceutical Co., Ltd. Recent Development Table 89. Jiangxi Haiersi Pharmaceutical Co., Ltd. Company Information Table 90. Jiangxi Haiersi Pharmaceutical Co., Ltd. Business Overview Table 91. Jiangxi Haiersi Pharmaceutical Co., Ltd. Isoniazid Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Jiangxi Haiersi Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio Table 93. Jiangxi Haiersi Pharmaceutical Co., Ltd. Recent Development Table 94. Jichuang Pharmaceutical Group Co., Ltd. Company Information Table 95. Jichuang Pharmaceutical Group Co., Ltd. Business Overview Table 96. Jichuang Pharmaceutical Group Co., Ltd. Isoniazid Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Jichuang Pharmaceutical Group Co., Ltd. Isoniazid Tablets Product Portfolio Table 98. Jichuang Pharmaceutical Group Co., Ltd. Recent Development Table 99. Hunan Xinhui Pharmaceutical Co., Ltd. Company Information Table 100. Hunan Xinhui Pharmaceutical Co., Ltd. Business Overview Table 101. Hunan Xinhui Pharmaceutical Co., Ltd. Isoniazid Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Hunan Xinhui Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio Table 103. Hunan Xinhui Pharmaceutical Co., Ltd. Recent Development Table 104. Hunan Shentaichun Pharmaceutical Co., Ltd. Company Information Table 105. Hunan Shentaichun Pharmaceutical Co., Ltd. Business Overview Table 106. Hunan Shentaichun Pharmaceutical Co., Ltd. Isoniazid Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Hunan Shentaichun Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio Table 108. Hunan Shentaichun Pharmaceutical Co., Ltd. Recent Development Table 109. Hunan Kangerjia Pharmaceutical Co., Ltd. Company Information Table 110. Hunan Kangerjia Pharmaceutical Co., Ltd. Business Overview Table 111. Hunan Kangerjia Pharmaceutical Co., Ltd. Isoniazid Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Hunan Kangerjia Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio Table 113. Hunan Kangerjia Pharmaceutical Co., Ltd. Recent Development Table 114. Hunan Hansen Pharmaceutical Co., Ltd. Company Information Table 115. Hunan Hansen Pharmaceutical Co., Ltd. Business Overview Table 116. Hunan Hansen Pharmaceutical Co., Ltd. Isoniazid Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Hunan Hansen Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio Table 118. Hunan Hansen Pharmaceutical Co., Ltd. Recent Development Table 119. Hunan Erkang Pharmaceutical Co., Ltd. Company Information Table 120. Hunan Erkang Pharmaceutical Co., Ltd. Business Overview Table 121. Hunan Erkang Pharmaceutical Co., Ltd. Isoniazid Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Hunan Erkang Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio Table 123. Hunan Erkang Pharmaceutical Co., Ltd. Recent Development Table 124. Hubei Renyue Pharmaceutical Co., Ltd. Company Information Table 125. Hubei Renyue Pharmaceutical Co., Ltd. Business Overview Table 126. Hubei Renyue Pharmaceutical Co., Ltd. Isoniazid Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Hubei Renyue Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio Table 128. Hubei Renyue Pharmaceutical Co., Ltd. Recent Development Table 129. Hubei Hendi Pharmaceutical Co., Ltd. Company Information Table 130. Hubei Hendi Pharmaceutical Co., Ltd. Business Overview Table 131. Hubei Hendi Pharmaceutical Co., Ltd. Isoniazid Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Hubei Hendi Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio Table 133. Hubei Hendi Pharmaceutical Co., Ltd. Recent Development Table 134. Hebei Changtian Pharmaceutical Co., Ltd. Company Information Table 135. Hebei Changtian Pharmaceutical Co., Ltd. Business Overview Table 136. Hebei Changtian Pharmaceutical Co., Ltd. Isoniazid Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Hebei Changtian Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio Table 138. Hebei Changtian Pharmaceutical Co., Ltd. Recent Development Table 139. Hebei Tiancheng Pharmaceutical Co., Ltd. Company Information Table 140. Hebei Tiancheng Pharmaceutical Co., Ltd. Business Overview Table 141. Hebei Tiancheng Pharmaceutical Co., Ltd. Isoniazid Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Hebei Tiancheng Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio Table 143. Hebei Tiancheng Pharmaceutical Co., Ltd. Recent Development Table 144. Hangzhou Minsheng Pharmaceutical Co., Ltd. Company Information Table 145. Hangzhou Minsheng Pharmaceutical Co., Ltd. Business Overview Table 146. Hangzhou Minsheng Pharmaceutical Co., Ltd. Isoniazid Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. Hangzhou Minsheng Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio Table 148. Hangzhou Minsheng Pharmaceutical Co., Ltd. Recent Development Table 149. Harbin Pharmaceutical Group Pharmaceutical Factory Company Information Table 150. Harbin Pharmaceutical Group Pharmaceutical Factory Business Overview Table 151. Harbin Pharmaceutical Group Pharmaceutical Factory Isoniazid Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 152. Harbin Pharmaceutical Group Pharmaceutical Factory Isoniazid Tablets Product Portfolio Table 153. Harbin Pharmaceutical Group Pharmaceutical Factory Recent Development Table 154. Sinopharm Guorui Pharmaceutical Co., Ltd. Company Information Table 155. Sinopharm Guorui Pharmaceutical Co., Ltd. Business Overview Table 156. Sinopharm Guorui Pharmaceutical Co., Ltd. Isoniazid Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 157. Sinopharm Guorui Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio Table 158. Sinopharm Guorui Pharmaceutical Co., Ltd. Recent Development Table 159. Guilin Nanyao Co., Ltd. Company Information Table 160. Guilin Nanyao Co., Ltd. Business Overview Table 161. Guilin Nanyao Co., Ltd. Isoniazid Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 162. Guilin Nanyao Co., Ltd. Isoniazid Tablets Product Portfolio Table 163. Guilin Nanyao Co., Ltd. Recent Development Table 164. Guangdong Xinfeng Pharmaceutical Co., Ltd. Company Information Table 165. Guangdong Xinfeng Pharmaceutical Co., Ltd. Business Overview Table 166. Guangdong Xinfeng Pharmaceutical Co., Ltd. Isoniazid Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 167. Guangdong Xinfeng Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio Table 168. Guangdong Xinfeng Pharmaceutical Co., Ltd. Recent Development Table 169. Key Raw Materials Table 170. Raw Materials Key Suppliers Table 171. Isoniazid Tablets Distributors List Table 172. Isoniazid Tablets Customers List Table 173. Research Programs/Design for This Report Table 174. Authors List of This Report Table 175. Secondary Sources Table 176. Primary Sources List of Figures Figure 1. Isoniazid Tablets Product Image Figure 2. Global Isoniazid Tablets Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Isoniazid Tablets Sales Value (2021-2032) & (US$ Million) Figure 4. Global Isoniazid Tablets Sales (2021-2032) & (K Units) Figure 5. Global Isoniazid Tablets Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Isoniazid Tablets Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 50mg Image Figure 10. 100mg Image Figure 11. Global Isoniazid Tablets Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Isoniazid Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Isoniazid Tablets Sales Volume Share by Type (2021-2032) Figure 14. Global Isoniazid Tablets Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Isoniazid Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Isoniazid Tablets Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Other Image Figure 20. Global Isoniazid Tablets Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Isoniazid Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Isoniazid Tablets Sales Volume Share by Application (2021-2032) Figure 23. Global Isoniazid Tablets Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Isoniazid Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Isoniazid Tablets Sales Value Share by Application (2021-2032) Figure 26. Global Isoniazid Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Isoniazid Tablets Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Isoniazid Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Isoniazid Tablets Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Isoniazid Tablets Sales Value (2021-2032) & (US$ Million) Figure 31. North America Isoniazid Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Isoniazid Tablets Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Isoniazid Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Isoniazid Tablets Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Isoniazid Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Isoniazid Tablets Sales Value (2021-2032) & (US$ Million) Figure 37. South America Isoniazid Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Isoniazid Tablets Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Isoniazid Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Isoniazid Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Isoniazid Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Isoniazid Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Isoniazid Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Isoniazid Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Isoniazid Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Isoniazid Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Isoniazid Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Isoniazid Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Isoniazid Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Isoniazid Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Isoniazid Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Isoniazid Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Isoniazid Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Isoniazid Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Isoniazid Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Isoniazid Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Isoniazid Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Isoniazid Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Isoniazid Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Isoniazid Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Isoniazid Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Isoniazid Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Isoniazid Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Isoniazid Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Isoniazid Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Isoniazid Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Isoniazid Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Isoniazid Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Isoniazid Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Isoniazid Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Isoniazid Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Isoniazid Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Isoniazid Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Isoniazid Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Isoniazid Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Isoniazid Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Isoniazid Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Isoniazid Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Isoniazid Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Isoniazid Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Isoniazid Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Isoniazid Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Isoniazid Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Isoniazid Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Isoniazid Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Isoniazid Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Isoniazid Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Isoniazid Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Isoniazid Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Isoniazid Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Isoniazid Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Isoniazid Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Isoniazid Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Isoniazid Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Isoniazid Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Isoniazid Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Isoniazid Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Isoniazid Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Isoniazid Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Isoniazid Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Isoniazid Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Isoniazid Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Isoniazid Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Isoniazid Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Isoniazid Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Isoniazid Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Isoniazid Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Isoniazid Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Isoniazid Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Isoniazid Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Isoniazid Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Isoniazid Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Isoniazid Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Isoniazid Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Isoniazid Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Isoniazid Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Isoniazid Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Isoniazid Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Isoniazid Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Isoniazid Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Isoniazid Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Isoniazid Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Isoniazid Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Isoniazid Tablets Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Isoniazid Tablets Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 50mg
  • 100mg
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Yunpeng Pharmaceutical Group Co., Ltd.
  • Tonghua Baishan Pharmaceutical Co., Ltd.
  • Tiansheng Pharmaceutical Group Co., Ltd.
  • Sichuan Deyuan Pharmaceutical Group Co., Ltd.
  • Sancai Shiqi Pharmaceutical Co., Ltd.
  • Jiangxi Haiersi Pharmaceutical Co., Ltd.
  • Jichuang Pharmaceutical Group Co., Ltd.
  • Hunan Xinhui Pharmaceutical Co., Ltd.
  • Hunan Shentaichun Pharmaceutical Co., Ltd.
  • Hunan Kangerjia Pharmaceutical Co., Ltd.
  • Hunan Hansen Pharmaceutical Co., Ltd.
  • Hunan Erkang Pharmaceutical Co., Ltd.
  • Hubei Renyue Pharmaceutical Co., Ltd.
  • Hubei Hendi Pharmaceutical Co., Ltd.
  • Hebei Changtian Pharmaceutical Co., Ltd.
  • Hebei Tiancheng Pharmaceutical Co., Ltd.
  • Hangzhou Minsheng Pharmaceutical Co., Ltd.
  • Harbin Pharmaceutical Group Pharmaceutical Factory
  • Sinopharm Guorui Pharmaceutical Co., Ltd.
  • Guilin Nanyao Co., Ltd.
  • Guangdong Xinfeng Pharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Isoniazid Tablets Sales Value (2021-2032)
  4. 1.2.2 Global Isoniazid Tablets Sales Volume (2021-2032)
  5. 1.2.3 Global Isoniazid Tablets Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Isoniazid Tablets Market Dynamics
  1. 2.1 Isoniazid Tablets Industry Trends
  2. 2.2 Isoniazid Tablets Industry Drivers
  3. 2.3 Isoniazid Tablets Industry Opportunities and Challenges
  4. 2.4 Isoniazid Tablets Industry Restraints
3 Isoniazid Tablets Market by Company
  1. 3.1 Global Isoniazid Tablets Company Revenue Ranking in 2025
  2. 3.2 Global Isoniazid Tablets Revenue by Company (2021-2026)
  3. 3.3 Global Isoniazid Tablets Sales Volume by Company (2021-2026)
  4. 3.4 Global Isoniazid Tablets Average Price by Company (2021-2026)
  5. 3.5 Global Isoniazid Tablets Company Ranking (2024-2026)
  6. 3.6 Global Isoniazid Tablets Company Manufacturing Base and Headquarters
  7. 3.7 Global Isoniazid Tablets Company Product Type and Application
  8. 3.8 Global Isoniazid Tablets Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Isoniazid Tablets Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Isoniazid Tablets Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Isoniazid Tablets Market by Type
  1. 4.1 Isoniazid Tablets Type Introduction
  2. 4.1.1 50mg
  3. 4.1.2 100mg
  4. 4.2 Global Isoniazid Tablets Sales Volume by Type
  5. 4.2.1 Global Isoniazid Tablets Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Isoniazid Tablets Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Isoniazid Tablets Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Isoniazid Tablets Sales Value by Type
  9. 4.3.1 Global Isoniazid Tablets Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Isoniazid Tablets Sales Value by Type (2021-2032)
  11. 4.3.3 Global Isoniazid Tablets Sales Value Share by Type (2021-2032)
5 Isoniazid Tablets Market by Application
  1. 5.1 Isoniazid Tablets Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Isoniazid Tablets Sales Volume by Application
  6. 5.2.1 Global Isoniazid Tablets Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Isoniazid Tablets Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Isoniazid Tablets Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Isoniazid Tablets Sales Value by Application
  10. 5.3.1 Global Isoniazid Tablets Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Isoniazid Tablets Sales Value by Application (2021-2032)
  12. 5.3.3 Global Isoniazid Tablets Sales Value Share by Application (2021-2032)
6 Isoniazid Tablets Regional Sales and Value Analysis
  1. 6.1 Global Isoniazid Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Isoniazid Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Isoniazid Tablets Sales by Region: 2021-2026
  4. 6.2.2 Global Isoniazid Tablets Sales by Region (2027-2032)
  5. 6.3 Global Isoniazid Tablets Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Isoniazid Tablets Sales Value by Region (2021-2032)
  7. 6.4.1 Global Isoniazid Tablets Sales Value by Region: 2021-2026
  8. 6.4.2 Global Isoniazid Tablets Sales Value by Region (2027-2032)
  9. 6.5 Global Isoniazid Tablets Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Isoniazid Tablets Sales Value (2021-2032)
  12. 6.6.2 North America Isoniazid Tablets Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Isoniazid Tablets Sales Value (2021-2032)
  15. 6.7.2 Europe Isoniazid Tablets Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Isoniazid Tablets Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Isoniazid Tablets Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Isoniazid Tablets Sales Value (2021-2032)
  21. 6.9.2 South America Isoniazid Tablets Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Isoniazid Tablets Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Isoniazid Tablets Sales Value Share by Country, 2025 VS 2032
7 Isoniazid Tablets Country-level Sales and Value Analysis
  1. 7.1 Global Isoniazid Tablets Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Isoniazid Tablets Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Isoniazid Tablets Sales by Country (2021-2032)
  4. 7.3.1 Global Isoniazid Tablets Sales by Country (2021-2026)
  5. 7.3.2 Global Isoniazid Tablets Sales by Country (2027-2032)
  6. 7.4 Global Isoniazid Tablets Sales Value by Country (2021-2032)
  7. 7.4.1 Global Isoniazid Tablets Sales Value by Country (2021-2026)
  8. 7.4.2 Global Isoniazid Tablets Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Isoniazid Tablets Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Isoniazid Tablets Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Isoniazid Tablets Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Isoniazid Tablets Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Isoniazid Tablets Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Isoniazid Tablets Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Isoniazid Tablets Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Isoniazid Tablets Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Isoniazid Tablets Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Isoniazid Tablets Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Isoniazid Tablets Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Isoniazid Tablets Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Isoniazid Tablets Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Isoniazid Tablets Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Isoniazid Tablets Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Isoniazid Tablets Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Isoniazid Tablets Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Isoniazid Tablets Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Isoniazid Tablets Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Isoniazid Tablets Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Isoniazid Tablets Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Isoniazid Tablets Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Isoniazid Tablets Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Isoniazid Tablets Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Isoniazid Tablets Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Isoniazid Tablets Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Isoniazid Tablets Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Isoniazid Tablets Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Isoniazid Tablets Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Isoniazid Tablets Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Isoniazid Tablets Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Isoniazid Tablets Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Isoniazid Tablets Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Isoniazid Tablets Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Isoniazid Tablets Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Isoniazid Tablets Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Isoniazid Tablets Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Isoniazid Tablets Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Isoniazid Tablets Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Isoniazid Tablets Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Isoniazid Tablets Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Isoniazid Tablets Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Isoniazid Tablets Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Isoniazid Tablets Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Isoniazid Tablets Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Isoniazid Tablets Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Isoniazid Tablets Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Isoniazid Tablets Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Isoniazid Tablets Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Isoniazid Tablets Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Isoniazid Tablets Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Isoniazid Tablets Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Isoniazid Tablets Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Isoniazid Tablets Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Isoniazid Tablets Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Isoniazid Tablets Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Isoniazid Tablets Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Isoniazid Tablets Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Isoniazid Tablets Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Isoniazid Tablets Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Isoniazid Tablets Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Isoniazid Tablets Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Isoniazid Tablets Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Isoniazid Tablets Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Isoniazid Tablets Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Isoniazid Tablets Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Isoniazid Tablets Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Isoniazid Tablets Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Isoniazid Tablets Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Isoniazid Tablets Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Isoniazid Tablets Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Isoniazid Tablets Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Isoniazid Tablets Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Isoniazid Tablets Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Isoniazid Tablets Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Isoniazid Tablets Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Isoniazid Tablets Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Isoniazid Tablets Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Isoniazid Tablets Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Isoniazid Tablets Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Isoniazid Tablets Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Isoniazid Tablets Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Isoniazid Tablets Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Isoniazid Tablets Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Yunpeng Pharmaceutical Group Co., Ltd.
  2. 8.1.1 Yunpeng Pharmaceutical Group Co., Ltd. Company Information
  3. 8.1.2 Yunpeng Pharmaceutical Group Co., Ltd. Business Overview
  4. 8.1.3 Yunpeng Pharmaceutical Group Co., Ltd. Isoniazid Tablets Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Yunpeng Pharmaceutical Group Co., Ltd. Isoniazid Tablets Product Portfolio
  6. 8.1.5 Yunpeng Pharmaceutical Group Co., Ltd. Recent Developments
  7. 8.2 Tonghua Baishan Pharmaceutical Co., Ltd.
  8. 8.2.1 Tonghua Baishan Pharmaceutical Co., Ltd. Company Information
  9. 8.2.2 Tonghua Baishan Pharmaceutical Co., Ltd. Business Overview
  10. 8.2.3 Tonghua Baishan Pharmaceutical Co., Ltd. Isoniazid Tablets Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Tonghua Baishan Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio
  12. 8.2.5 Tonghua Baishan Pharmaceutical Co., Ltd. Recent Developments
  13. 8.3 Tiansheng Pharmaceutical Group Co., Ltd.
  14. 8.3.1 Tiansheng Pharmaceutical Group Co., Ltd. Company Information
  15. 8.3.2 Tiansheng Pharmaceutical Group Co., Ltd. Business Overview
  16. 8.3.3 Tiansheng Pharmaceutical Group Co., Ltd. Isoniazid Tablets Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Tiansheng Pharmaceutical Group Co., Ltd. Isoniazid Tablets Product Portfolio
  18. 8.3.5 Tiansheng Pharmaceutical Group Co., Ltd. Recent Developments
  19. 8.4 Sichuan Deyuan Pharmaceutical Group Co., Ltd.
  20. 8.4.1 Sichuan Deyuan Pharmaceutical Group Co., Ltd. Company Information
  21. 8.4.2 Sichuan Deyuan Pharmaceutical Group Co., Ltd. Business Overview
  22. 8.4.3 Sichuan Deyuan Pharmaceutical Group Co., Ltd. Isoniazid Tablets Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Sichuan Deyuan Pharmaceutical Group Co., Ltd. Isoniazid Tablets Product Portfolio
  24. 8.4.5 Sichuan Deyuan Pharmaceutical Group Co., Ltd. Recent Developments
  25. 8.5 Sancai Shiqi Pharmaceutical Co., Ltd.
  26. 8.5.1 Sancai Shiqi Pharmaceutical Co., Ltd. Company Information
  27. 8.5.2 Sancai Shiqi Pharmaceutical Co., Ltd. Business Overview
  28. 8.5.3 Sancai Shiqi Pharmaceutical Co., Ltd. Isoniazid Tablets Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Sancai Shiqi Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio
  30. 8.5.5 Sancai Shiqi Pharmaceutical Co., Ltd. Recent Developments
  31. 8.6 Jiangxi Haiersi Pharmaceutical Co., Ltd.
  32. 8.6.1 Jiangxi Haiersi Pharmaceutical Co., Ltd. Company Information
  33. 8.6.2 Jiangxi Haiersi Pharmaceutical Co., Ltd. Business Overview
  34. 8.6.3 Jiangxi Haiersi Pharmaceutical Co., Ltd. Isoniazid Tablets Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Jiangxi Haiersi Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio
  36. 8.6.5 Jiangxi Haiersi Pharmaceutical Co., Ltd. Recent Developments
  37. 8.7 Jichuang Pharmaceutical Group Co., Ltd.
  38. 8.7.1 Jichuang Pharmaceutical Group Co., Ltd. Company Information
  39. 8.7.2 Jichuang Pharmaceutical Group Co., Ltd. Business Overview
  40. 8.7.3 Jichuang Pharmaceutical Group Co., Ltd. Isoniazid Tablets Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Jichuang Pharmaceutical Group Co., Ltd. Isoniazid Tablets Product Portfolio
  42. 8.7.5 Jichuang Pharmaceutical Group Co., Ltd. Recent Developments
  43. 8.8 Hunan Xinhui Pharmaceutical Co., Ltd.
  44. 8.8.1 Hunan Xinhui Pharmaceutical Co., Ltd. Company Information
  45. 8.8.2 Hunan Xinhui Pharmaceutical Co., Ltd. Business Overview
  46. 8.8.3 Hunan Xinhui Pharmaceutical Co., Ltd. Isoniazid Tablets Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Hunan Xinhui Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio
  48. 8.8.5 Hunan Xinhui Pharmaceutical Co., Ltd. Recent Developments
  49. 8.9 Hunan Shentaichun Pharmaceutical Co., Ltd.
  50. 8.9.1 Hunan Shentaichun Pharmaceutical Co., Ltd. Company Information
  51. 8.9.2 Hunan Shentaichun Pharmaceutical Co., Ltd. Business Overview
  52. 8.9.3 Hunan Shentaichun Pharmaceutical Co., Ltd. Isoniazid Tablets Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Hunan Shentaichun Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio
  54. 8.9.5 Hunan Shentaichun Pharmaceutical Co., Ltd. Recent Developments
  55. 8.10 Hunan Kangerjia Pharmaceutical Co., Ltd.
  56. 8.10.1 Hunan Kangerjia Pharmaceutical Co., Ltd. Company Information
  57. 8.10.2 Hunan Kangerjia Pharmaceutical Co., Ltd. Business Overview
  58. 8.10.3 Hunan Kangerjia Pharmaceutical Co., Ltd. Isoniazid Tablets Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Hunan Kangerjia Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio
  60. 8.10.5 Hunan Kangerjia Pharmaceutical Co., Ltd. Recent Developments
  61. 8.11 Hunan Hansen Pharmaceutical Co., Ltd.
  62. 8.11.1 Hunan Hansen Pharmaceutical Co., Ltd. Company Information
  63. 8.11.2 Hunan Hansen Pharmaceutical Co., Ltd. Business Overview
  64. 8.11.3 Hunan Hansen Pharmaceutical Co., Ltd. Isoniazid Tablets Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Hunan Hansen Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio
  66. 8.11.5 Hunan Hansen Pharmaceutical Co., Ltd. Recent Developments
  67. 8.12 Hunan Erkang Pharmaceutical Co., Ltd.
  68. 8.12.1 Hunan Erkang Pharmaceutical Co., Ltd. Company Information
  69. 8.12.2 Hunan Erkang Pharmaceutical Co., Ltd. Business Overview
  70. 8.12.3 Hunan Erkang Pharmaceutical Co., Ltd. Isoniazid Tablets Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Hunan Erkang Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio
  72. 8.12.5 Hunan Erkang Pharmaceutical Co., Ltd. Recent Developments
  73. 8.13 Hubei Renyue Pharmaceutical Co., Ltd.
  74. 8.13.1 Hubei Renyue Pharmaceutical Co., Ltd. Company Information
  75. 8.13.2 Hubei Renyue Pharmaceutical Co., Ltd. Business Overview
  76. 8.13.3 Hubei Renyue Pharmaceutical Co., Ltd. Isoniazid Tablets Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Hubei Renyue Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio
  78. 8.13.5 Hubei Renyue Pharmaceutical Co., Ltd. Recent Developments
  79. 8.14 Hubei Hendi Pharmaceutical Co., Ltd.
  80. 8.14.1 Hubei Hendi Pharmaceutical Co., Ltd. Company Information
  81. 8.14.2 Hubei Hendi Pharmaceutical Co., Ltd. Business Overview
  82. 8.14.3 Hubei Hendi Pharmaceutical Co., Ltd. Isoniazid Tablets Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Hubei Hendi Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio
  84. 8.14.5 Hubei Hendi Pharmaceutical Co., Ltd. Recent Developments
  85. 8.15 Hebei Changtian Pharmaceutical Co., Ltd.
  86. 8.15.1 Hebei Changtian Pharmaceutical Co., Ltd. Company Information
  87. 8.15.2 Hebei Changtian Pharmaceutical Co., Ltd. Business Overview
  88. 8.15.3 Hebei Changtian Pharmaceutical Co., Ltd. Isoniazid Tablets Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Hebei Changtian Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio
  90. 8.15.5 Hebei Changtian Pharmaceutical Co., Ltd. Recent Developments
  91. 8.16 Hebei Tiancheng Pharmaceutical Co., Ltd.
  92. 8.16.1 Hebei Tiancheng Pharmaceutical Co., Ltd. Company Information
  93. 8.16.2 Hebei Tiancheng Pharmaceutical Co., Ltd. Business Overview
  94. 8.16.3 Hebei Tiancheng Pharmaceutical Co., Ltd. Isoniazid Tablets Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Hebei Tiancheng Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio
  96. 8.16.5 Hebei Tiancheng Pharmaceutical Co., Ltd. Recent Developments
  97. 8.17 Hangzhou Minsheng Pharmaceutical Co., Ltd.
  98. 8.17.1 Hangzhou Minsheng Pharmaceutical Co., Ltd. Company Information
  99. 8.17.2 Hangzhou Minsheng Pharmaceutical Co., Ltd. Business Overview
  100. 8.17.3 Hangzhou Minsheng Pharmaceutical Co., Ltd. Isoniazid Tablets Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Hangzhou Minsheng Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio
  102. 8.17.5 Hangzhou Minsheng Pharmaceutical Co., Ltd. Recent Developments
  103. 8.18 Harbin Pharmaceutical Group Pharmaceutical Factory
  104. 8.18.1 Harbin Pharmaceutical Group Pharmaceutical Factory Company Information
  105. 8.18.2 Harbin Pharmaceutical Group Pharmaceutical Factory Business Overview
  106. 8.18.3 Harbin Pharmaceutical Group Pharmaceutical Factory Isoniazid Tablets Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Harbin Pharmaceutical Group Pharmaceutical Factory Isoniazid Tablets Product Portfolio
  108. 8.18.5 Harbin Pharmaceutical Group Pharmaceutical Factory Recent Developments
  109. 8.19 Sinopharm Guorui Pharmaceutical Co., Ltd.
  110. 8.19.1 Sinopharm Guorui Pharmaceutical Co., Ltd. Company Information
  111. 8.19.2 Sinopharm Guorui Pharmaceutical Co., Ltd. Business Overview
  112. 8.19.3 Sinopharm Guorui Pharmaceutical Co., Ltd. Isoniazid Tablets Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Sinopharm Guorui Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio
  114. 8.19.5 Sinopharm Guorui Pharmaceutical Co., Ltd. Recent Developments
  115. 8.20 Guilin Nanyao Co., Ltd.
  116. 8.20.1 Guilin Nanyao Co., Ltd. Company Information
  117. 8.20.2 Guilin Nanyao Co., Ltd. Business Overview
  118. 8.20.3 Guilin Nanyao Co., Ltd. Isoniazid Tablets Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Guilin Nanyao Co., Ltd. Isoniazid Tablets Product Portfolio
  120. 8.20.5 Guilin Nanyao Co., Ltd. Recent Developments
  121. 8.21 Guangdong Xinfeng Pharmaceutical Co., Ltd.
  122. 8.21.1 Guangdong Xinfeng Pharmaceutical Co., Ltd. Company Information
  123. 8.21.2 Guangdong Xinfeng Pharmaceutical Co., Ltd. Business Overview
  124. 8.21.3 Guangdong Xinfeng Pharmaceutical Co., Ltd. Isoniazid Tablets Sales, Value and Gross Margin (2021-2026)
  125. 8.21.4 Guangdong Xinfeng Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio
  126. 8.21.5 Guangdong Xinfeng Pharmaceutical Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Isoniazid Tablets Value Chain Analysis
  2. 9.1.1 Isoniazid Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Isoniazid Tablets Sales Mode & Process
  6. 9.2 Isoniazid Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Isoniazid Tablets Distributors
  9. 9.2.3 Isoniazid Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst